VOR · NASDAQ
Vor Biopharma (VOR) Stock Price & Fundamentals
Vor Biopharma (VOR) closed at $585.68 on Oct 9, 2026, down 0.83% from the previous close of $590.57.
Share price, past year
1Y +39.28%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $585.68 |
| Sep 30, 2026 | $589.10 |
| Aug 31, 2026 | $581.40 |
| Jul 31, 2026 | $541.95 |
| Jun 30, 2026 | $536.89 |
| May 29, 2026 | $531.21 |
| Apr 30, 2026 | $508.39 |
| Mar 31, 2026 | $477.73 |
| Feb 27, 2026 | $483.87 |
| Jan 30, 2026 | $471.98 |
| Dec 31, 2025 | $471.70 |
| Nov 28, 2025 | $429.20 |
| Oct 31, 2025 | $420.23 |
Key statistics
- Market cap
- $31.89B
- P/E (TTM)
- 3.3
- EPS (TTM)
- $179.68
- Net income (TTM)
- $627.78M
- Shares outstanding
- 54.5M
- 52-week range
- $416.92 – $605.61
Vor Biopharma's market cap is $31.89B, based on a share price of $585.68 and 54.5M shares outstanding as of Jun 30, 2026.
Financials
Vor Biopharma's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Vor Biopharma reported a net loss of $695.98M in fiscal 2025.
Company profile
- Name
- Vor Biopharma Inc.
- Ticker
- VOR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 500 Boylston Street, Suite 1350, Boston, MA 02116
- Fiscal year ends
- December
- SEC CIK
- 0001817229
Recent SEC filings
- Aug 11, 2026
- Jul 7, 2026
- Jun 12, 2026
- Jun 8, 2026
- May 13, 2026
- Mar 30, 2026
- Mar 27, 2026
- Jan 12, 2026
Frequently asked questions
What is Vor Biopharma's stock price?
Vor Biopharma (VOR) closed at $585.68 on Oct 9, 2026, down 0.83% from the previous close of $590.57.
What is Vor Biopharma's market cap?
Vor Biopharma's market cap is $31.89B, based on a share price of $585.68 and 54.5M shares outstanding as of Jun 30, 2026.
What is VOR's P/E ratio?
Vor Biopharma's price-to-earnings ratio is 3.3, based on trailing twelve-month diluted EPS of $179.68.
Does Vor Biopharma pay a dividend?
Vor Biopharma's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Vor Biopharma Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures